Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies
| Autor: | Hanno M Witte, Svenja Kopelke, Alexander Fürschke, Nikolaus von Bubnoff, Carsten Hackenbroch, Arthur Bauer, Alex Frydrychowicz, Armin Riecke, Britta Mengler, Sebastian Fetscher, Niklas Gebauer |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Oncology Cancer Research medicine.medical_specialty Multivariate analysis Follicular lymphoma Young Adult Risk Factors Multicenter trial Internal medicine Tumor Microenvironment medicine Humans Prospective Studies Lymphoma Follicular Aged Retrospective Studies Aged 80 and over Inflammation Univariate analysis Hematology Proportional hazards model business.industry General Medicine Middle Aged Antigens CD20 Prognosis medicine.disease Clinical trial Cohort business |
| Zdroj: | Journal of Cancer Research and Clinical Oncology. 148:1789-1801 |
| ISSN: | 1432-1335 0171-5216 |
| Popis: | Background The composition of the tumor microenvironment (TME) is conditioned by immunity and the inflammatory response. Nutritional and inflammation-based risk scores have emerged as relevant predictors of survival outcome across a variety of hematological malignancies. Methods In this retrospective multicenter trial, we ascertained the prognostic impact of established nutritional and inflammation-based risk scores [Glasgow Prognostic Score (GPS), C-reactive–protein/albumin ratio (CAR), neutrophil–lymphocyte ratio (NLR), prognostic nutritional index (PNI), and prognostic index (PI)] in 209 eligible patients with histologically confirmed CD20+ follicular lymphoma (FL) of WHO grade 1 (37.3%), 1–2 (16.3%), 2 (26.8%) or 3A (19.8%) admitted to the participating centers between January 2000 and December 2019. Characteristics significantly associated with overall or progression-free survival (OS, PFS) upon univariate analysis were subsequently included in a Cox proportional hazard model. Results In the study cohort, the median age was 63 (range 22–90 years). The median follow-up period covered 99 months. The GPS and the CAR were identified to predict survival in FL patients. The GPS was the only independent predictor of OS (p p = 0.001; HR 1.995; 95% CI 1.352–2.944) upon multivariate analysis. Additionally, there was frequent occurrence of progression of disease within 24 months (POD24) in FL patients with a calculated GPS of 2. Conclusion The current results indicate that the GPS predicts especially OS in FL patients. Moreover, GPS was found to display disease-specific effects in regard to FL progression. These findings and potential combinations with additional established prognosticators should be further validated within prospective clinical trials. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink